• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尽管化疗使肿瘤负荷增加,但骨髓瘤蛋白仍无分泌。

Nonsecretion of myeloma protein in spite of an increase in tumor burden by chemotherapy.

作者信息

Kubota K, Kurabayashi H, Kawada E, Okamoto K, Tamura J, Shirakura T

机构信息

Department of Medicine, Kusatsu Branch Hospital, Gunma University School of Medicine, Japan.

出版信息

Ann Hematol. 1991 Oct;63(4):232-3. doi: 10.1007/BF01703451.

DOI:10.1007/BF01703451
PMID:1932306
Abstract

A unique case of IgA kappa myeloma is presented. While the myeloma cells had secreted a large quantity of IgA kappa monoclonal protein, they were induced to stop secreting the monoclonal protein by cyclophosphamide and vincristine, in spite of a remarkable increase in tumor burden. The absence of intracytoplasmic IgA kappa was clearly evidenced by the immunofluorescence technique using anti-IgA and anti-kappa monoclonal antibodies.

摘要

本文报告了一例独特的IgA κ型骨髓瘤病例。尽管骨髓瘤细胞分泌了大量的IgA κ单克隆蛋白,但在使用环磷酰胺和长春新碱治疗后,尽管肿瘤负荷显著增加,这些细胞却被诱导停止分泌单克隆蛋白。使用抗IgA和抗κ单克隆抗体的免疫荧光技术清楚地证明了胞浆内不存在IgA κ。

相似文献

1
Nonsecretion of myeloma protein in spite of an increase in tumor burden by chemotherapy.尽管化疗使肿瘤负荷增加,但骨髓瘤蛋白仍无分泌。
Ann Hematol. 1991 Oct;63(4):232-3. doi: 10.1007/BF01703451.
2
[Intracytoplasmic crystals and Fanconi syndrome in a patient with IgA kappa myeloma].[一名IgA κ型骨髓瘤患者的胞浆内晶体与范科尼综合征]
Nefrologia. 2001 Mar-Apr;21(2):213-6.
3
Characterization and use of the novel human multiple myeloma cell line MC-B11/14 to study biological consequences of CRISPR-mediated loss of immunoglobulin A heavy chain.新型人类多发性骨髓瘤细胞系MC-B11/14的表征及应用,以研究CRISPR介导的免疫球蛋白A重链缺失的生物学后果
Exp Hematol. 2018 Jan;57:42-49.e1. doi: 10.1016/j.exphem.2017.09.010. Epub 2017 Oct 13.
4
[Monoclonal rheumatoid factor in a patient with multiple myeloma after chemotherapy].[化疗后多发性骨髓瘤患者的单克隆类风湿因子]
Nihon Rinsho Meneki Gakkai Kaishi. 1996 Oct;19(5):519-23. doi: 10.2177/jsci.19.519.
5
Vindesine in refractory multiple myeloma.长春地辛治疗难治性多发性骨髓瘤。
Cancer. 1986 Jan 15;57(2):226-9. doi: 10.1002/1097-0142(19860115)57:2<226::aid-cncr2820570207>3.0.co;2-i.
6
Long-term remission of paraprotein-induced immunotactoid glomerulopathy after high-dose therapy and autologous blood stem cell transplantation.大剂量治疗及自体造血干细胞移植后副蛋白诱导的免疫触须样肾小球病长期缓解
Ann Hematol. 2007 Dec;86(12):927-30. doi: 10.1007/s00277-007-0330-6. Epub 2007 Jun 29.
7
[Plasmocytic pleural effusion disclosing multiple myeloma].[浆细胞性胸腔积液揭示多发性骨髓瘤]
Rev Mal Respir. 2000 Apr;17(2):495-7.
8
[Immunoblastic lymphoma as expression of the final phase of IgA multiple myeloma].[免疫母细胞淋巴瘤作为IgA多发性骨髓瘤终末期的表现]
Rev Clin Esp. 1992 Oct;191(5):267-9.
9
Infusion of lymphocytes obtained from a donor immunised with the paraprotein idiotype as a treatment in a relapsed myeloma.
Bone Marrow Transplant. 2000 May;25(10):1105-8. doi: 10.1038/sj.bmt.1702399.
10
Myeloma with two monoclonal IgG and IgD in serum: a case report.血清中存在两种单克隆IgG和IgD的骨髓瘤:一例报告
Acta Haematol. 1994;92(3):144-7. doi: 10.1159/000204206.

本文引用的文献

1
Decreasing M spike with increasing tumor burden in multiple myeloma.多发性骨髓瘤中M蛋白峰随肿瘤负荷增加而降低。
Arch Intern Med. 1981 Aug;141(9):1152-3.
2
[Contribution to the problem of plasmacytoma without paraproteins].[关于无副蛋白浆细胞瘤问题的贡献]
Dtsch Med Wochenschr. 1968 Oct 25;93(43):2072-5. doi: 10.1055/s-0028-1110881.
3
Multiple myeloma: significance of plasmablastic subtype in morphological classification.多发性骨髓瘤:浆母细胞亚型在形态学分类中的意义
Blood. 1985 Feb;65(2):305-10.
4
Clinical features of common acute lymphoblastic leukemia antigen (CALLA)-positive myeloma: report of four cases.普通急性淋巴细胞白血病抗原(CALLA)阳性骨髓瘤的临床特征:4例报告
Blut. 1989 May;58(5):229-33. doi: 10.1007/BF00320910.
5
A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival.一种多发性骨髓瘤的临床分期系统。测量的骨髓瘤细胞量与初始临床特征、治疗反应及生存情况的相关性。
Cancer. 1975 Sep;36(3):842-54. doi: 10.1002/1097-0142(197509)36:3<842::aid-cncr2820360303>3.0.co;2-u.